Keyphrases
Morphine
91%
Opiates
52%
Nicotine
41%
Analgesia
36%
Naloxone
27%
Catalepsy
24%
Substance P
22%
Nicotine Dependence
20%
Naltrexone
20%
Enkephalin
19%
Seizure
17%
Neurotransmitters
17%
Primary Afferent
17%
Epileptic
17%
Smokers
17%
Analgesic
16%
Intrathecal
16%
Anticonvulsant
16%
Ventrolateral Periaqueductal Gray (vlPAG)
16%
Opiate Receptors
16%
Anticonvulsant Action
15%
Convulsion
15%
Intrathecal Administration
13%
Kainic Acid
13%
Dextromethorphan
13%
Electroconvulsive Shock
13%
Endogenous Opioids
12%
Methionine
12%
Intrathecal Injection
11%
N-methyl-D-aspartate Receptor (NMDAR)
10%
High Dose
10%
Pain Threshold
9%
Hypothermia
9%
Picrotoxin
9%
Pain Behavior
8%
Amygdaloid Kindling
8%
Food Intake
8%
Suppressant
8%
Water Intake
8%
Urge to Smoke
8%
Newborn Rats
8%
Opioid System
8%
Visual Evoked Potentials
8%
N-methyl-D-aspartate
8%
Electrographic Seizures
8%
Methadone
8%
Methionine Enkephalin
8%
Supraspinal
8%
Receptor Antagonist
7%
Amino
7%
Neuroscience
Morphine
100%
Opiate
60%
Behavior (Neuroscience)
48%
Intrathecal
38%
Tobacco Dependence
30%
Naloxone
24%
Catalepsy
22%
Substance P
22%
Anticonvulsant
21%
Receptor
20%
Naltrexone
18%
Endorphin
18%
Neurotransmitter
17%
Enkephalin
16%
Periaqueductal Gray
15%
Pain Threshold
15%
Kindling
13%
Hypothermia
13%
Metenkephalinamide
11%
Dextro Aspartic Acid
11%
Strychnine
9%
Leu-Enkephalin
9%
Gray Matter
9%
Dextromethorphan
8%
Visual Evoked Potential
8%
Kainic Acid
8%
Methadone
8%
Met-Enkephalin
8%
Nociception
7%
Receptor Antagonist
7%
Glutamic Acid
7%
Convulsant
7%
Cholecystokinin
6%
Withdrawal Syndrome
6%
Dextrorphan
6%
Proglumide
5%
Behavioral Effect
5%
Ontogeny
5%
Multielectrode Array
5%
Catatonia
5%
Pharmacology, Toxicology and Pharmaceutical Science
Morphine
24%
Intrathecal
21%
Tobacco Dependence
17%
Substance P
13%
Naloxone
9%
Anticonvulsive Agent
9%
Neurotransmitter
8%
Dextromethorphan
8%
Kainic Acid
8%
Dextrorphan
7%
Opiate
7%
Subcutaneous Injection
6%
Picrotoxin
5%
3 Hydroxy 2 Quinoxalinecarboxylic Acid
5%
Dextro Aspartic Acid
5%